Weger M - Search Results

1

Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.

Weger M, Stanger O, Deutschmann H, Temmel W, Renner W, Schmut O, Semmelrock J, Haas A. Weger M, et al. Graefes Arch Clin Exp Ophthalmol. 2002 Apr;240(4):286-90. doi: 10.1007/s00417-002-0431-9. Epub 2002 Feb 21. Graefes Arch Clin Exp Ophthalmol. 2002. PMID: 11981642

2

Measuring patient activation: the utility of the Patient Activation Measure administered in an interview setting.

Holter M, Avian A, Weger M, Strini S, Michelitsch M, Brenk-Franz K, Wedrich A, Berghold A. Holter M, et al. Among authors: weger m. Qual Life Res. 2024 May;33(5):1389-1400. doi: 10.1007/s11136-024-03614-2. Epub 2024 Feb 22. Qual Life Res. 2024. PMID: 38388807 Free PMC article.

3

Incomplete renal tubular acidosis in 'primary' osteoporosis.

Weger M, Deutschmann H, Weger W, Kotanko P, Skrabal F. Weger M, et al. Among authors: weger w. Osteoporos Int. 1999;10(4):325-9. doi: 10.1007/s001980050235. Osteoporos Int. 1999. PMID: 10692983

4

Prevalence and characterization of renal tubular acidosis in patients with osteopenia and osteoporosis and in non-porotic controls.

Weger W, Kotanko P, Weger M, Deutschmann H, Skrabal F. Weger W, et al. Among authors: weger m. Nephrol Dial Transplant. 2000 Jul;15(7):975-80. doi: 10.1093/ndt/15.7.975. Nephrol Dial Transplant. 2000. PMID: 10862634

5

The impact of diets with different magnesium contents on magnesium and calcium in serum and tissues of the rat.

Zimmermann P, Weiss U, Classen HG, Wendt B, Epple A, Zollner H, Temmel W, Weger M, Porta S. Zimmermann P, et al. Among authors: weger m. Life Sci. 2000 Jul 14;67(8):949-58. doi: 10.1016/s0024-3205(00)00688-3. Life Sci. 2000. PMID: 10946854

6

Hyperhomocysteinemia: a risk factor for central retinal vein occlusion.

Weger M, Stanger O, Haas A. Weger M, et al. Am J Ophthalmol. 2001 Feb;131(2):290-1. doi: 10.1016/s0002-9394(00)00789-3. Am J Ophthalmol. 2001. PMID: 11243255 No abstract available.

7

Hyperhomocyst(e)inaemia, but not MTHFR C677T mutation, as a risk factor for non-arteritic ischaemic optic neuropathy.

Weger M, Stanger O, Deutschmann H, Simon M, Renner W, Schmut O, Semmelrock J, Haas A. Weger M, et al. Br J Ophthalmol. 2001 Jul;85(7):803-6. doi: 10.1136/bjo.85.7.803. Br J Ophthalmol. 2001. PMID: 11423453 Free PMC article.

8

Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease.

Stanger O, Weger M, Renner W, Konetschny R. Stanger O, et al. Among authors: weger m. Clin Chem Lab Med. 2001 Aug;39(8):725-33. doi: 10.1515/CCLM.2001.121. Clin Chem Lab Med. 2001. PMID: 11592442 Review.

9

Role of factor XIII Val34Leu polymorphism in retinal artery occlusion.

Weger M, Renner W, Stanger O, Schmut O, Deutschmann H, Wascher TC, Haas A. Weger M, et al. Stroke. 2001 Dec 1;32(12):2759-61. doi: 10.1161/hs1201.99889. Stroke. 2001. PMID: 11739969

10

Chlamydia pneumoniae seropositivity and the risk of nonarteritic ischemic optic neuropathy.

Weger M, Haas A, Stanger O, El-Shabrawi Y, Temmel W, Maier R, Berghold A, Haller-Schober EM. Weger M, et al. Ophthalmology. 2002 Apr;109(4):749-52. doi: 10.1016/s0161-6420(01)01031-4. Ophthalmology. 2002. PMID: 11927434

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters